Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Hi Tech Pharmaceuticals
WARNING LETTER
•Hi Tech Pharmaceuticals•April 16, 2019

Hi Tech Pharmaceuticals – FDA Warning Letter, Apr 16, 2019

Record Details

The FDA issued a Warning Letter to Hi-Tech Pharmaceuticals, Inc. on April 10, 2019, regarding their dietary supplement products Ultimate Orange, HydroxyElite, Lipodrene Elite, and Synadrene. The letter states that these products are adulterated because they contain 2-Aminoisoheptane HCl (DMHA), which is declared as a dietary ingredient.

The FDA asserts that DMHA is a "new dietary ingredient" as it was not marketed in the U.S. before October 15, 1994, and there is no evidence of its prior presence in the food supply as an unchemically altered food article. Therefore, a new dietary ingredient notification (NDIN) was required under section 413(a)(2) of the Act and 21 CFR 190.6, which was not submitted. Even if an NDIN had been submitted, the FDA knows of no evidence establishing DMHA's safety for use as a dietary ingredient, making products containing it adulterated under sections 402(f) and 413(a) of the Act due to inadequate safety assurance.

Furthermore, the FDA questions whether DMHA is, in fact, a dietary ingredient. If not, it would be considered an unsafe food additive, rendering the products adulterated under section 402(a)(2)(C)(i) of the Act, as it

Company
Hi Tech Pharmaceuticals
Inspection date
April 16, 2019
Product type
Food
Office
Center for Food Safety and Applied Nutrition
Person
  • William A. Correll (Director)
View Company Profile

ID · fefad51f-7f45-4738-936d-6f4d2894a644

Violation Codes10
21 U.S.C. 321(ff)21 U.S.C. 321(ff)(1)21 U.S.C. 350b(d)21 U.S.C. 350b21 U.S.C. 342(f)21 U.S.C. 350b(a)(2)21 CFR 190.621 U.S.C. 350b(a)21 U.S.C. 331(v)21 U.S.C. 342(a)(C)(i)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Hi Tech Pharmaceuticals
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.